Catecholamine
The family of fight-and-flight transmitters. Dopamine, norepinephrine, and epinephrine share one biosynthetic pathway and one chemical core — three siblings with different day jobs.
Neurotransmitter Class Biogenic amines (catechol nucleus)
Release Sites Brain catecholamine nuclei, sympathetic nerves, adrenal medulla
Clearance Reuptake transporters; MAO and COMT enzymes
Net Effect Neuromodulatory — gain control on whole systems
Synthesis & Release
One pipeline: tyrosine hydroxylase (the rate-limiting enzyme) makes L-DOPA, DOPA decarboxylase makes dopamine, dopamine beta-hydroxylase adds the hydroxyl for norepinephrine, and PNMT methylates it to epinephrine — mostly in the adrenal medulla . Which product a cell ships depends on which enzymes it expresses: dopaminergic neurons stop at step two; chromaffin cells run the full line.
Receptor Actions
Dopamine receptors: D1-like excitation, D2-like inhibition — movement, reward, psychosis pharmacology.
Alpha and beta adrenergic receptors: vascular, cardiac, and metabolic targets of sympathetic output.
All G-protein coupled: catecholamines are modulators, not fast transmitters.
Physiological Role
Movement and reward: dopamine's basal ganglia and mesolimbic roles — the dopaminergic neuron is the unit.
Arousal and attention: noradrenergic locus coeruleus projections set alertness.
Systemic stress: adrenal epinephrine — the hormonal arm of the same family.
Interactions
Individual members have their own entries: dopamine , norepinephrine , epinephrine — canonical in the hormone registry as dual-role molecules.
Reuptake by NET and DAT terminates signaling; antidepressants and stimulants work here.
Degradation by MAO and COMT sets the baseline — the pharmacology of MAO inhibitors.
Clinical Relevance
Parkinson disease: dopaminergic loss treated with L-DOPA — the pathway in the clinic.
Pheochromocytoma, heart failure, shock: catecholamine medicine spans surgery to ICU.
Psychostimulants and antipsychotics both target this family's transport and receptors.
The pathway's enzymes are each a disease or drug target: tyrosine hydroxylase to L-DOPA, MAO to antidepressants, COMT to catechol drugs.
Catecholamine nuclei are few and small — a handful of cell groups modulating the whole brain by projection arithmetic.
The metabolites — HVA, VMA, metanephrines — are the clinical readouts of the family's turnover.
Sources
Directory Synapse Registry Human Biology Hub